CXCL9 may serve as a potential biomarker for primary Sjogren's syndrome with extra-glandular manifestations. Hong J, Cheng H, Wang P, Wu Y, et al. Arthritis Res Ther 2024;26:26.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hong J, Cheng H, Wang P, Wu Y, et al. CXCL9 may serve as a potential biomarker for primary Sjogren's syndrome with extra-glandular manifestations. Arthritis Res Ther 2024;26:26.
PMID: 38229121